215 related articles for article (PubMed ID: 8154492)
1. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus.
Quereda C; Otero GG; Pardo A; Orte L; Rivera M; Gonzalo A; Pascual J; Ortuño J
Am J Kidney Dis; 1994 Apr; 23(4):555-61. PubMed ID: 8154492
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
[TBL] [Abstract][Full Text] [Related]
3. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
5. "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome.
Charney DA; Nassar G; Truong L; Nadasdy T
Am J Kidney Dis; 2000 Jun; 35(6):1193-206. PubMed ID: 10845835
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Cervera R; García-Carrasco M; Font J; Ramos M; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
Clin Exp Rheumatol; 1997; 15(4):361-5. PubMed ID: 9272295
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
[TBL] [Abstract][Full Text] [Related]
8. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
9. [Anti-phospholipid syndrome nephropathy].
Nochy D; Daugas E; Hill G; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
Love PE; Santoro SA
Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
[TBL] [Abstract][Full Text] [Related]
12. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
Silvariño R; Sant F; Espinosa G; Pons-Estel G; Solé M; Cervera R; Arrizabalaga P
Lupus; 2011 Jun; 20(7):721-9. PubMed ID: 21486929
[TBL] [Abstract][Full Text] [Related]
13. Epileptic seizures in systemic lupus erythematosus.
Appenzeller S; Cendes F; Costallat LT
Neurology; 2004 Nov; 63(10):1808-12. PubMed ID: 15557494
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
[TBL] [Abstract][Full Text] [Related]
15. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
16. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
17. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
[TBL] [Abstract][Full Text] [Related]
19. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.
Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B
Lupus; 1998; 7(2):124-31. PubMed ID: 9541097
[TBL] [Abstract][Full Text] [Related]
20. Renal involvement in antiphospholipid syndrome.
de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
